deltatrials
Completed PHASE1 INTERVENTIONAL 3-arm NCT01317667

Safety and Immunogenicity Study of Recombinant Ricin Toxin A-Chain Vaccine (RVEc™)

Phase 1 Escalating, Multiple-Dose Study to Evaluate the Safety and Immunogenicity of Recombinant Ricin Toxin A-Chain 1-33/44-198 (rRTA 1-33/44-198) Vaccine (RVEc™) in Healthy Adults

Sponsor: U.S. Army Medical Research and Development Command

Conditions Ricin
Interventions RVEc
Updated 11 times since 2017 Last updated: Dec 30, 2019 Started: Mar 31, 2011 Primary completion: Nov 30, 2012 Completion: Dec 31, 2014
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Ricin, this trial is completed. The trial is conducted by U.S. Army Medical Research and Development Command and has accumulated 11 data snapshots since 2011. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotCompleted~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshotCompleted~Jun 2018 – ~Aug 2019 · 14 months · monthly snapshotCompleted~Aug 2019 – ~Feb 2020 · 6 months · monthly snapshotCompleted~Feb 2020 – ~Jan 2021 · 11 months · monthly snapshotCompleted~Jan 2021 – ~Oct 2021 · 9 months · monthly snapshotCompleted~Oct 2021 – ~Dec 2022 · 14 months · monthly snapshotCompleted~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshotCompleted~Jan 2023 – ~Jul 2024 · 18 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

11 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1

  3. Jan 2023 — Jul 2024 [monthly]

    Completed PHASE1

  4. Dec 2022 — Jan 2023 [monthly]

    Completed PHASE1

  5. Oct 2021 — Dec 2022 [monthly]

    Completed PHASE1

▶ Show 6 earlier versions

  1. Jan 2021 — Oct 2021 [monthly]

    Completed PHASE1

  2. Feb 2020 — Jan 2021 [monthly]

    Completed PHASE1

  3. Aug 2019 — Feb 2020 [monthly]

    Completed PHASE1

  4. Jun 2018 — Aug 2019 [monthly]

    Completed PHASE1

  5. Feb 2017 — Jun 2018 [monthly]

    Completed PHASE1

  6. Jan 2017 — Feb 2017 [monthly]

    Completed PHASE1

    First recorded

Mar 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • U.S. Army Medical Research and Development Command
  • US Army Medical Research Institute of Infectious Diseases
Data source: U.S. Army Medical Research and Development Command

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations